Dr Martens falls after Barclays cuts rating to 'underweight'

By Reuters News

** Shares of bootmaker Dr Martens DOCS.L down 4.1% at 62.9 p

** Stock among top losers on mid-caps .FTMC, which is marginally up

** Barclays cuts rating to "underweight" from "equal-weight", trims PT to 60p from 70p

** Cites subdued brand search momentum ahead of key selling quarter, macroeconomic weakness in major markets and a promotional footwear market

** Three of six analysts covering the stock have a "buy" or higher rating and 3 has "hold" ; median PT is 95p - LSEG-compiled data

**YTD, stock down about 16% vs about 9% rise in .FTMC

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk